Method for producing dual function proteins and its derivatives
AssigneeYuhan Corporation
InventorsByung Hyun CHOI, In Hwan LIM, Jun Young PARK, Jin Hyoung LEE, Ki Hong KIM, Hae Yong JO, Jun KIM, Moo Young SONG, Jong Gyun KIM
Life of this patent
Estimating the term…
Abstract
A method for producing a dual function protein includes a biologically active protein and an FGF21 mutant protein. The method allows stable production of a target protein by effectively preventing decomposition of the target protein, and thus has a high potential for commercial usage.
Claims8
A method for producing a recombinant dual function protein from a mammalian host cell transformed with an expression vector containing cDNA encoding a dual function protein or a derivative thereof, the method comprising culturing the mammalian host cell in a culture medium supplemented with dextran sulfate, wherein the dual function protein comprises a fibroblast growth factor 21 (FGF21) mutant protein;
- a biologically active protein, or a mutant or fragment thereof;
- and an Fc region of an immunoglobulin, wherein the FGF21 mutant protein comprises at least one mutation selected from the group consisting of the mutations (1) to (7) below:
- (1) a substitution of amino acids at positions 98 to 101 from the N-terminus of a wild-type FGF21 protein with the amino acid sequence of EIRP (SEQ ID NO:
- 53);
- (2) a substitution of amino acids at positions 170 to 174 from the N-terminus of a wild-type FGF21 protein with the amino acid sequence of TGLEAV (SEQ ID NO:
- 54);
- (3) a substitution of amino acids at positions 170 to 174 from the N-terminus of a wild-type FGF21 protein with the amino acid sequence of TGLEAN (SEQ ID NO:
- 55);
- (4) a substitution of an amino acid at position 170 from the N-terminus of a wild-type FGF21 protein with the amino acid N;
- (5) a substitution of an amino acid at position 174 from the N-terminus of a wild-type FGF21 protein with the amino acid N;
- (6) a substitution of an amino acid at position 180 from the N-terminus of a wild-type FGF21 protein with the amino acid E, along with one or more mutations (1) to (5) above;
- and
- (7) a mutation of 1 to 10 amino acids for reducing immunogenicity of a wild-type FGF21 protein.
Dependencies are inferred from the claim text.